Treatment News : Quadruple Dose of Flu Vaccine Works Better Among People With HIV

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » January 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

January 8, 2013

Quadruple Dose of Flu Vaccine Works Better Among People With HIV

Administering a quadruple dose of flu vaccine to people with HIV helps erase the deficit of flu protection they appear to experience compared with the general population, MedPage Today reports. Seeking greater insight into the results of past studies that have shown reduced antibody response to flu vaccines among people with HIV, researchers at the MacGregor Infectious Disease Clinic of the Hospital of the University of Pennsylvania conducted a study of 195 HIV-positive participants who received either the standard flu vaccine dose or a dose four-times the standard. The scientists published their results in the Annals of Internal Medicine.

Most participants completed the study—97 in the quadruple-dose group and 93 in the standard-dose cohort. The respective seroprotection rates for various strains of the flu among the high- versus the low-dose group were as follows: H1N1: 96 percent vs. 87 percent; N3N2: 96 percent vs. 92 percent; and influenza B: 91 percent vs. 80 percent. Both of the doses proved well-tolerated: 10 percent of each group experienced tenderness at the injection site; 13 percent of the high-dose group and 14.7 percent of the low-dose group had malaise; and a respective 19 percent versus 18 percent experienced myalgia (general pain).

The study was limited by its small size and the small number of participants with fewer than 200 CD4 cells.


To read the MedPage Today report, click here.

To read the study abstract, click here.

Search: HIV, flu, vaccine, quadruple, high, dose, MedPage Today, H1N1, N3N2, influenza B, myalgia, malaise, tenderness, MacGregor Infectious Disease Clinic of the Hospital of the University of Pennsylvania.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         


[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Should the U.S. gay blood ban end?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.